LONDON, England, July 21 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on July 20, 2026:

* * *

European Medicines Agency accepts submission to update Bexsero label for 1-dose Meningitis B booster in 10+ year olds

* If approved, a single booster dose could help protect individuals who were previously vaccinated with Bexsero

-

GSK plc (LSE/NYSE: GSK) today announced the European Med . . .

Click here for more information about our products